In another move designed to reduce the US' reliance on imported medicines, the FDA has launched a pilot of fast-track reviews for generics tested and made in domestic facilities. According to the ...
Gharda CEO Ram Seethapathi outlines how generics reshaped chlorpyrifos — from pricing power to global access — and what it ...
Pacira BioSciences faces significant risk as generic challenges threaten Exparel, its flagship product responsible for 78% of 2024 revenue. PCRX's complex formulation, robust patent estate, and ...
President Donald Trump’s top health advisers announced a push to cut health costs by bringing more cutting-edge generic drugs to market in a press conference on Wednesday. The Food and Drug ...
Jamie Dimon is right to be alarmed about our national-security vulnerabilities, especially an overreliance on China and India for generic prescription drugs (“Investments for National Security,” op-ed ...
The pharma sector is in focus and all pharma stocks are surging. This is after a Wall Street Journal report indicated that the Trump administration may not impose tariffs on generic medicines. There ...
President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...
Generics Awareness Month took center stage at the Mercury Drug Q-Plaza Branch in Cainta recently, where RHEA Generics, in support of the Department of Health (DOH) and in partnership with Mercury Drug ...
US President Donald Trump’s latest tariff missile imposing a 100% levy on branded or patented pharmaceuticals is unlikely to have much impact on India’s drug industry that mostly ships generic or ...
Shares in AbbVie were climbing today after the company revealed that it has settled litigation with generic drugmakers and should prevent generic competition for its big-selling Rinvoq brand in the US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback